hidradenitis suppurativa, MLM Medical Labs, Dermatology Research

MLM Participates in Important Non-Inverventional Hidradenitis Suppurativa (HS) Study

MLM Medical Labs Supports Leading Biotech Company in a Non-Interventional Hidradenitis Suppurativa (HS) Study MLM Medical Labs – Minneapolis recently partnered with a leading biotech company on the CSL324 study of a novel, fully human anti-G-CSF receptor (G-CSFR) monoclonal antibody in the treatment of hidradenitis suppurativa (HS).  CSL324 is being investigated as a potential treatment in […]

MLM Participates in Important Non-Inverventional Hidradenitis Suppurativa (HS) Study Read More »

Thrombosis and Hemostasis Assays

The Advantages of Custom Thrombosis and Hemostasis Assays in Early Therapeutic Development

It is never too soon to start thinking about establishing an early-stage hematology testing paradigm to evaluate therapeutic candidates’ potential side effects. Join our Global Chief Scientific Officer and internationally recognized KOL in hematology, Lisa K. Jennings, as she shares the benefits of utilizing custom hematology-based assays in determining MOAs and pathways behind drug development across a range of therapeutic areas.

The Advantages of Custom Thrombosis and Hemostasis Assays in Early Therapeutic Development Read More »